CO4940484A1 - Mezcla de acidos grasos primarios de alto peso molecular obtenidos de la cana de azucar y metodos de obtencion - Google Patents
Mezcla de acidos grasos primarios de alto peso molecular obtenidos de la cana de azucar y metodos de obtencionInfo
- Publication number
- CO4940484A1 CO4940484A1 CO98018329A CO98018329A CO4940484A1 CO 4940484 A1 CO4940484 A1 CO 4940484A1 CO 98018329 A CO98018329 A CO 98018329A CO 98018329 A CO98018329 A CO 98018329A CO 4940484 A1 CO4940484 A1 CO 4940484A1
- Authority
- CO
- Colombia
- Prior art keywords
- carbon atoms
- mixture
- fatty acids
- well
- sugar cane
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 11
- 235000014113 dietary fatty acids Nutrition 0.000 title abstract 8
- 229930195729 fatty acid Natural products 0.000 title abstract 8
- 239000000194 fatty acid Substances 0.000 title abstract 8
- 150000004665 fatty acids Chemical class 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 10
- 240000000111 Saccharum officinarum Species 0.000 abstract 3
- 235000007201 Saccharum officinarum Nutrition 0.000 abstract 3
- 150000001298 alcohols Chemical class 0.000 abstract 3
- 229930195733 hydrocarbon Natural products 0.000 abstract 3
- 150000002430 hydrocarbons Chemical class 0.000 abstract 3
- 150000002576 ketones Chemical class 0.000 abstract 3
- 239000003960 organic solvent Substances 0.000 abstract 3
- 150000003839 salts Chemical group 0.000 abstract 3
- 150000001491 aromatic compounds Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 239000003929 acidic solution Substances 0.000 abstract 1
- 230000002785 anti-thrombosis Effects 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 150000004679 hydroxides Chemical class 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- -1 mixtures of these Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000001953 recrystallisation Methods 0.000 abstract 1
- 238000010992 reflux Methods 0.000 abstract 1
- 238000007127 saponification reaction Methods 0.000 abstract 1
- 238000000956 solid--liquid extraction Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1997035A CU22723A1 (es) | 1997-04-02 | 1997-04-02 | Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4940484A1 true CO4940484A1 (es) | 2000-07-24 |
Family
ID=5459247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO98018329A CO4940484A1 (es) | 1997-04-02 | 1998-04-01 | Mezcla de acidos grasos primarios de alto peso molecular obtenidos de la cana de azucar y metodos de obtencion |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6486205B2 (OSRAM) |
| EP (1) | EP0969827B1 (OSRAM) |
| JP (2) | JP4907750B2 (OSRAM) |
| CN (1) | CN1230158C (OSRAM) |
| AR (1) | AR016054A1 (OSRAM) |
| AT (1) | ATE233087T1 (OSRAM) |
| AU (1) | AU732045B2 (OSRAM) |
| BR (1) | BR9808470A (OSRAM) |
| CA (1) | CA2285242C (OSRAM) |
| CO (1) | CO4940484A1 (OSRAM) |
| CU (1) | CU22723A1 (OSRAM) |
| DE (1) | DE69811643T2 (OSRAM) |
| DK (1) | DK0969827T3 (OSRAM) |
| ES (1) | ES2192769T3 (OSRAM) |
| MY (1) | MY120318A (OSRAM) |
| PT (1) | PT969827E (OSRAM) |
| RU (1) | RU2217130C2 (OSRAM) |
| WO (1) | WO1998043631A1 (OSRAM) |
| ZA (1) | ZA982744B (OSRAM) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4666705B2 (ja) * | 1999-12-07 | 2011-04-06 | 三井製糖株式会社 | 消化管潰瘍予防剤または改善剤 |
| US20030203854A1 (en) * | 2002-04-23 | 2003-10-30 | Ivo Pischel | Composition for effecting serum cholesterol levels |
| US7649103B2 (en) * | 2002-06-17 | 2010-01-19 | Medestea Research And Production S.R.L. | Long chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field |
| US20050074443A1 (en) * | 2003-10-03 | 2005-04-07 | Treadwell Benjamin V. | Methods of attenuating autoimmune disease and compositions useful therefor |
| US20060013842A1 (en) * | 2004-07-15 | 2006-01-19 | Matkin John R | Natural mixture of long-chain fatty alcohols and long-chain fatty acids, its obtension from animal and vegetable waxes and its nutraceutical uses |
| US7542034B2 (en) * | 2004-09-23 | 2009-06-02 | Conversion Works, Inc. | System and method for processing video images |
| KR100723950B1 (ko) * | 2005-01-04 | 2007-05-31 | 주식회사 하이폭시 | 벼과 식물 추출물을 포함하는 허혈성 질환 및 퇴행성뇌질환의 예방 및 치료를 위한 조성물 |
| KR100685681B1 (ko) * | 2005-07-26 | 2007-02-26 | 전북대학교산학협력단 | 수수에서 폴리코사놀 또는 옥타코사놀 함량이 높은긴사슬지방을 제조하는 방법 |
| TW200730518A (en) * | 2005-10-12 | 2007-08-16 | Sicor Inc | Crystalline forms of docetaxel and processes for their preparation |
| US20070295326A1 (en) * | 2006-06-07 | 2007-12-27 | Rafael Almagro | Method for obtaining long chain aliphatic alcohols and fatty acids from sugar cane mud and related wax esters |
| US20080207748A1 (en) * | 2007-02-22 | 2008-08-28 | Innovation Labs, Inc. | Vitamin c preparation |
| DE102010052789A1 (de) * | 2010-11-27 | 2012-05-31 | Wachs-Chemie Elsteraue E.K. | Herstellung und Reinigung von PC-Wachs und deren technische Anwendungen |
| IT201700089258A1 (it) | 2017-08-02 | 2019-02-02 | Pharmanutra S P A | Composizione per uso nella prevenzione e nel trattamento di carenza di ferro |
| KR102429853B1 (ko) * | 2017-11-30 | 2022-08-05 | (주)아모레퍼시픽 | 천연 왁스를 이용한 지방산 조성물 제조방법 및 그에 따라 제조된 지방산 조성물 |
| IT201900007311A1 (it) | 2019-05-27 | 2020-11-27 | Alesco Srl | Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati |
| IT201900007329A1 (it) * | 2019-05-27 | 2020-11-27 | Alesco Srl | Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia |
| IT201900007326A1 (it) | 2019-05-27 | 2020-11-27 | Alesco Srl | Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari |
| CU24638B1 (es) * | 2020-02-03 | 2023-01-16 | Centro Nac De Investigaciones Cientificas | Suspensión oral con efecto antiulceroso y quimioprotector sobre el cáncer de colon |
| CU24732B1 (es) * | 2021-07-13 | 2025-02-07 | Centro Nac De Investigaciones Cientificas | Mezcla de compuestos con altos pesos moleculares, obtenida a partir de la cera de caña de azúcar (saccharum officinarum l.) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5160207A (en) * | 1974-11-22 | 1976-05-26 | Dai Ichi Kogyo Seiyaku Co Ltd | Shibosanto kokyuarukooruno bunriho |
| JPH0610146B2 (ja) * | 1985-10-12 | 1994-02-09 | 住友精化株式会社 | 直鎖第１級脂肪族高級アルコ−ルの抽出法 |
| DE69026496D1 (de) * | 1989-10-13 | 1996-05-15 | Neurofit | Analoge von vitamin a und ihre verwendung, insbesondere als cytotrophische und cytoprotective substanzen sowie diese substanzen enthaltende arzneimittel |
| CU22225A1 (es) * | 1990-11-30 | 1995-01-31 | Cent Nac Investig Scient | Composicion farmacautica que contiene mezcla de alcoholes alifaticos primarios superiores para el tratamiento de hipercolesterolemia y la hiperlipoproteinemia tipo ii asi como estimulante de la conducta sexual en animales y humanos |
| CU22229A1 (es) * | 1992-09-29 | 1996-01-31 | Dalmer Lab Sa | Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la |
| JPH06122892A (ja) * | 1992-10-09 | 1994-05-06 | Nippon Petrochem Co Ltd | 粗ワックスの製造方法 |
| CU22412A1 (es) * | 1993-11-09 | 1996-01-31 | Dalmer Lab Sa | Una mezcla natural compuesta por alcoholes alifaticos primarios superiores obtenidos de la cera de abejas para el tratamiento de las ulceras gastricas y duodenales que presenta tambien actividad antiinflamatoria |
| US5554379A (en) * | 1994-06-20 | 1996-09-10 | Kv Pharmaceutical Company | Long acting GI and esophageal protectant |
| JP2804445B2 (ja) * | 1994-11-30 | 1998-09-24 | ラボラトリオス ダルマー ソシエダッド アノニマ | 胃潰瘍および十二指腸潰瘍の処置剤および抗炎症剤 |
| US6039950A (en) * | 1995-04-14 | 2000-03-21 | University Of Southern California | Pharmaceutical grade saw palmetto |
| US6080787A (en) * | 1997-02-21 | 2000-06-27 | Abbott Laboratories | Methods for reducing the incidence of necrotizing enterocolitis |
| AUPO605097A0 (en) * | 1997-04-07 | 1997-05-01 | James Cook University Of North Queensland | Food grade wax and process for preparing same |
-
1997
- 1997-04-02 CU CU1997035A patent/CU22723A1/es unknown
-
1998
- 1998-04-01 RU RU99123062/14A patent/RU2217130C2/ru active
- 1998-04-01 US US09/402,292 patent/US6486205B2/en not_active Expired - Fee Related
- 1998-04-01 WO PCT/IB1998/000870 patent/WO1998043631A1/en not_active Ceased
- 1998-04-01 BR BR9808470-4A patent/BR9808470A/pt not_active Application Discontinuation
- 1998-04-01 MY MYPI98001431A patent/MY120318A/en unknown
- 1998-04-01 PT PT98920719T patent/PT969827E/pt unknown
- 1998-04-01 CN CNB988055880A patent/CN1230158C/zh not_active Expired - Lifetime
- 1998-04-01 CA CA002285242A patent/CA2285242C/en not_active Expired - Lifetime
- 1998-04-01 ES ES98920719T patent/ES2192769T3/es not_active Expired - Lifetime
- 1998-04-01 AU AU73494/98A patent/AU732045B2/en not_active Expired
- 1998-04-01 AT AT98920719T patent/ATE233087T1/de not_active IP Right Cessation
- 1998-04-01 CO CO98018329A patent/CO4940484A1/es unknown
- 1998-04-01 JP JP54135598A patent/JP4907750B2/ja not_active Expired - Lifetime
- 1998-04-01 EP EP98920719A patent/EP0969827B1/en not_active Expired - Lifetime
- 1998-04-01 DE DE69811643T patent/DE69811643T2/de not_active Expired - Lifetime
- 1998-04-01 ZA ZA982744A patent/ZA982744B/xx unknown
- 1998-04-01 DK DK98920719T patent/DK0969827T3/da active
- 1998-04-02 AR ARP980101504A patent/AR016054A1/es active IP Right Grant
-
2011
- 2011-11-16 JP JP2011250436A patent/JP2012067119A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1230158C (zh) | 2005-12-07 |
| RU2217130C2 (ru) | 2003-11-27 |
| JP2001518092A (ja) | 2001-10-09 |
| CA2285242C (en) | 2008-12-16 |
| MY120318A (en) | 2005-10-31 |
| JP4907750B2 (ja) | 2012-04-04 |
| DK0969827T3 (da) | 2003-06-16 |
| ES2192769T3 (es) | 2003-10-16 |
| DE69811643D1 (de) | 2003-04-03 |
| AR016054A1 (es) | 2001-06-20 |
| BR9808470A (pt) | 2000-05-23 |
| CA2285242A1 (en) | 1998-10-08 |
| CN1258218A (zh) | 2000-06-28 |
| AU7349498A (en) | 1998-10-22 |
| WO1998043631A1 (en) | 1998-10-08 |
| JP2012067119A (ja) | 2012-04-05 |
| DE69811643T2 (de) | 2003-12-24 |
| EP0969827A1 (en) | 2000-01-12 |
| ZA982744B (en) | 1998-10-08 |
| US20020058705A1 (en) | 2002-05-16 |
| ATE233087T1 (de) | 2003-03-15 |
| PT969827E (pt) | 2003-07-31 |
| US6486205B2 (en) | 2002-11-26 |
| HK1029054A1 (en) | 2001-03-23 |
| EP0969827B1 (en) | 2003-02-26 |
| AU732045B2 (en) | 2001-04-12 |
| CU22723A1 (es) | 2002-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kerr et al. | 2-Hydroxy-saclofen: an improved antagonist at central and peripheral GABAB receptors | |
| US4816479A (en) | Xanthone derivatives and process for producing the same | |
| RU99123062A (ru) | Смесь первичных жирных кислот, получаемых из сахарно-тросникового воска | |
| BE1001473A3 (fr) | Procede de separation d'impuretes formatrices d'odeurs de substances aromatiques du houblon et substances ainsi obtenues. | |
| AR013019A1 (es) | Polisacarido de sintesis, su utilizacion y composiciones farmaceuticas que lo contienen | |
| AR013051A1 (es) | Aislacion y purificacion de esteroles a partir de fracciones neutras de resina de tallol mediante cristalizacion de decantacion unica | |
| JP2001518092A (ja) | サトウキビ・ワックスから得られる第一級脂肪酸の混合物 | |
| EA199900833A1 (ru) | Способ очистки капролактама | |
| ES2168266T3 (es) | Procedimiento para la eliminacion de fracciones de peso molecular mas bajo de polimeros de poli(sulfuro de arileno). | |
| RU2009108271A (ru) | Способ очистки монтелукаста | |
| JPH05221864A (ja) | （＋）−３−（４−フェニル−１−ピペラジニル）−１，２−プロパンジオールを有効成分とする鎮静剤 | |
| RU96106660A (ru) | Способ очистки нефтяных шламов и грунтов | |
| NO171846C (no) | Fremgangsmaate for gjenvinning av melkesyre fra vandige medier inneholdende denne | |
| Morrison | Chikungunya fever | |
| Kwan et al. | Effects of hypoxia on the pharmacological responsiveness of isolated coronary artery rings from the sheep | |
| JP2006510632A (ja) | 置換２，３−ベンゾジアゼピン類による過敏性腸症候群及び非潰瘍性消化不良の治療 | |
| FR2436817A1 (fr) | Procede d'elimination des sels de potassium des sous-produits de distillation | |
| ES2135099T3 (es) | Procedimiento para la purificacion de polieteres, poliesteres, y esteres de polieter. | |
| FR2522660A1 (fr) | Isomere levogyre de la mequitazine, son procede de preparation et medicaments le contenant | |
| EP0894794A1 (en) | Optical isomers of cloperastine | |
| Dudley | Insulin from the cod fish: the direct application of picric acid to the islet tissue | |
| Wilkinson et al. | The biological action of substances related to thyroxine. 4. The thyroxine-inhibitory properties of a series of 4-hydroxy-3: 5-diiodobenzoates of glycols | |
| JPS6130676B2 (OSRAM) | ||
| Fretland et al. | Effect of the leukotriene B4 receptor antagonist, SC-41930, on experimental allergic encephalomyelitis (EAE) in the guinea pig | |
| AR241751A1 (es) | Procedimiento para obtener mezclas de gangliosidos para el tratamiento de enfermedades psico-organicas y del caracter. |